Sorafenib for Hepatopulmonary Syndrome

NCT02021929 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Hepatopulmonary Syndrome

Interventions

DRUG: Sorafenib
DRUG: Placebo

Sponsor

University of Pennsylvania

Collaborators

[object Object]